A microbiota-directed complementary food intervention in 12-18-month-old Bangladeshi children improves linear growth - Mostafa, Ishita; Hibberd, Matthew C.; Hartman, Steven J.; Rahman, Md Hasan Hafizur; Mahfuz, Mustafa; Hasan, S. M. Tafsir; Ashorn, Per; Barratt, Michael J.; Ahmed, Tahmeed; Gordon, Jeffrey I. (medRxiv, 2024)
Background Globally, stunting affects ∼150 million children under five, while wasting affects nearly 50 million. Current interventions have had limited effectiveness in ameliorating long-term sequelae of undernutrition including stunting, cognitive deficits and immune dysfunction. Disrupted development of the gut microbiota has been linked to the pathogenesis of undernutrition, providing potentially new treatment approaches.Methods 124 Bangladeshi children with moderate acute malnutrition (MAM) enrolled (at 12-18 months) in a previously reported 3-month RCT of a microbiota-directed complementary food (MDCF-2) were followed for two years. Weight and length were monitored by anthropometry, the abundances of bacterial strains were assessed by quantifying metagenome-assembled genomes (MAGs) in serially collected fecal samples and levels of growth-associated proteins were measured in plasma.Findings Children who had received MDCF-2 were significantly less stunted during follow-up than those who received a standard ready-to-use supplementary food (RUSF) [linear mixed-effects model, βtreatment group x study week (95% CI) = 0.002 (0.001, 0.003); P=0.004]. They also had elevated fecal abundances of Agathobacter faecis, Blautia massiliensis, Lachnospira and Dialister, plus increased levels of a group of 37 plasma proteins (linear model; FDR-adjusted P<0.1), including IGF-1, neurotrophin receptor NTRK2 and multiple proteins linked to musculoskeletal and CNS development, that persisted for 6-months post-intervention.Interpretation MDCF-2 treatment of Bangladeshi children with MAM, which produced significant improvements in wasting during intervention, also reduced stunting during follow-up. These results suggest that the effectiveness of supplementary foods for undernutrition may be improved by including ingredients that sponsor healthy microbiota-host co-development.Funding This work was supported by the BMGF (Grants OPP1134649/INV-000247). ClinicalTrials.gov identifier: NCT04015999Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04015999Funding StatementThis work was supported by the Bill and Melinda Gates Foundation (Grants OPP1134649/INV-000247).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Review Committee (ERC) of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data supporting the findings of this study are available within the supplementary materials; shotgun sequencing data in raw format (prior to post-processing and data analysis) have been deposited at the European Nucleotide Archive (ENA) under study accession PRJEB66487. https://www.ebi.ac.uk/ena/browser/view/PRJEB66487